Le Lézard
Classified in: Oil industry, Business

Lariat Partners Invests in Offen Petroleum


DENVER, Jan. 10, 2018 /PRNewswire/ -- Lariat Partners ("Lariat"), a Denver-based private equity firm, announced today that it has made a significant investment in Offen Petroleum ("Offen" or the "Company"), a leading independent provider of fuel, lubricants, and logistics services in Colorado and the Rocky Mountain region.

Offen traces its roots to the 1930s and was acquired by Bill Gallagher and Gwen Stukey in 1997.  The Company has grown to over 500 million gallons annually and today serves as both a branded and unbranded wholesale fuel supplier.  Offen sources and sells fuel in 12 states.  In addition to fuels, Offen's lubricants division provides products and solutions for the commercial, industrial, and passenger car segments, as well as diesel exhaust fluids used in emission controls.  The Company operates a specialty logistics division that is a premier fuel carrier throughout Colorado. 

"The strategic investment that Lariat Partners has made in our company will continue to fuel our growth," states Bill Gallagher, Offen Petroleum's CEO.  "We have consistently grown over the past 20 years and this investment from Lariat will allow us to continue expanding into new markets through both greenfield locations and strategic add-on acquisitions."

Jay Coughlon, Managing Partner at Lariat Partners, said "Offen is one of the few platforms of scale with a comprehensive team, state-of-the-art facilities, modern distribution fleet, and significant purchasing power that services Colorado and the broader Rocky Mountain region.  Lariat backs strong entrepreneurs that have a proven ability to execute growth strategies.  Offen's consumable product offerings, 20-year history, strong management team, and exciting growth plans make it an ideal fit for our investment strategy.  We are thrilled to partner with Bill Gallagher and his team."

More information on Offen can be found at www.offenpetro.com.

About Lariat Partners
Denver-based Lariat Partners is a private equity firm focused on redefining the private equity experience in the lower-middle market.  With its People First, Strategy Second relationship philosophy and its CORE investment strategy targeting Consolidations, Consumables and Recurring Revenue businesses, Lariat offers a differentiated approach to partnering with entrepreneurs and growing their middle market businesses.  The firm targets companies across a number of industries, including Specialty Distribution, Energy & Environmental Services, Food & Agribusiness, Consumer Products and Maritime Services.  For more information, visit www.lariatpartners.net

About Stephens Inc.
Stephens Inc. served as exclusive financial advisor to Offen Petroleum, Inc. in the transaction.

Contact: Chris Tofalli
Chis Tofalli Public Relations, LLC
914-834-4334

SOURCE Lariat Partners


These press releases may also interest you

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...

at 22:10
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: